Bluesight has acquired Protenus to enhance its healthcare compliance capabilities and strengthen its drug diversion platform.

Target Information

Bluesight, based in Alexandria, Virginia, is a premier provider of inventory management, procurement, and compliance solutions tailored for health systems and hospital pharmacies. The company has announced its acquisition of Protenus, a leading provider of healthcare compliance analytics solutions. This acquisition aims to further enhance Bluesight’s existing drug diversion platform while integrating essential patient privacy monitoring capabilities, thereby bolstering protections for healthcare organizations and the communities they serve.

Established in 2014, Protenus has emerged as a market leader, leveraging artificial intelligence to offer scalable risk-reduction solutions that prioritize patient safety and operational excellence. With a robust client base across hundreds of healthcare organizations throughout the United States, Protenus has built strong, trustworthy relationships, managing substantial operational and reputational risks in the healthcare domain.

Industry Overview in the United States

The healthcare compliance analytics industry in the United States is rapidly evolving, driven by increasing regulatory requirements and heightened scrutiny over patient data protection. Organization